A Controlled Trial of Synthetic Surfactant in Infants Weighing 1250 G or More with Respiratory Distress Syndrome

Abstract
Surfactant-replacement therapy is now recognized as a lifesaving and safe intervention in small premature infants, but there is little evidence concerning its risks and benefits in larger premature infants.

This publication has 16 references indexed in Scilit: